European agency panel recommends approval of J&J’s Ebola vaccine
FILE PHOTO: The company logo for Johnson & Johnson is displayed to celebrate the 75th anniversary of the company’s listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid (Reuters) – A panel of the European health regulator on Friday recommended approving Johnson & Johnson’s two-dose experimental vaccine… Read More »